With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.22876-19-3,5-Chlorobenzo[d]oxazole-2(3H)-thione,as a common compound, the synthetic route is as follows.
Step 4b. A mixture of compound from step 4a (1.6 g, 8.6 mmol), Mel (1.8 g, 12.9 mmol) and K2CO3 in DMF (20 mL) was stirred for 5 hours at 50C before was partitioned (EtO Ac-brine). The organic was dried (Na2S04), filtered and concentrated to give the desired compound (1.2 g, 70%) as a yellow oil. ESI-MS m/z =199.90, 201.90 [M+H]+. This material was used directly in the next step without further purification.
22876-19-3 5-Chlorobenzo[d]oxazole-2(3H)-thione 708870, abenzoxazole compound, is more and more widely used in various.
Reference£º
Patent; ENANTA PHARMACEUTICALS, INC.; QIU, Yao-ling; LI, Wei; CAO, Hui; JIN, Meizhong; GAO, Xuri; PENG, Xiaowen; KASS, Jorden; OR, Yat, Sun; (84 pag.)WO2016/183266; (2016); A1;,
Benzoxazole – Wikipedia
Benzoxazole | C7H5NO – PubChem